Searched for
PHARMA AND IT SECTORS STABILITY
Dalal Street Week Ahead: Lower volatility signals calm, but resistance looms largeIndian markets concluded the week on a strong note, driven by consistent buying interest and a significant drop in volatility. The Nifty in...
Sun Pharma adds Innovcare to its fold in Rs 271.2 crore all-cash transactionIndia's largest drugmaker, Sun Pharma, is set to acquire Mumbai-based Innovcare Lifesciences for approximately $28.7 million in an all-cash...
India's IT sector facing a growth crisis; Daljeet Kohli says he's already walked awayIndia's IT sector faces uncertainty as global slowdown and AI fears spook investors. Market expert Daljeet Kohli advises caution, citing a ...
Explained: Why Accenture's warning sparked a Rs 1.35 lakh crore meltdown for TCS, Infosys, other IT stocksIndian IT majors faced a brutal sell-off, losing Rs 1.35 lakh crore after Accenture's revenue guidance cut. Structural fears around AI repl...
Accenture signals caution, but analysts see long-term IT opportunityAccenture's earnings signal tough times for IT services. Indian IT firms face weak demand and cautious client spending. While valuations ar...
Accenture's weak bookings raise AI fears, but Indian IT may weather the storm: Sandip AgarwalAccenture's recent earnings reveal a sharp decline in new bookings and a reduced guidance, sparking concerns about AI's impact on the IT se...
Power and IT set to remain dominant industries as pvt sector leads India's investment landscape in post-Covid era: ReportPower and IT sectors are set to lead India's economic growth. New investment announcements show a strong focus on electricity and technolog...
Christy Mathai used market dip to buy insurance, logistics stocks; here's his sector-by-sector playbookFund Manager Christy Mathai sees easing war-driven inflation fears, expecting a shorter earnings hit. He's selectively adding to his portfo...
Infosys, TCS, Wipro, other IT stocks fall up to 3% after Fed's hawkish tone. What's ahead?Indian IT stocks, including Infosys and TCS, experienced a significant decline of up to 3% on Thursday. This downturn was triggered by a ha...
Realtors eye margin relief as US-Iran peace deal raises hopes of lower fuel costsA potential peace deal between the US and Iran offers hope for India's real estate and construction sectors. Developers are watching oil pr...
API prices fall as West Asia tensions ease, boosting Indian pharma sectorPrices for active pharmaceutical ingredients have seen a decline of five to ten percent, thanks to the calming geopolitical climate in West...
IT rebound may lack legs, outlook remains cautious: Sunil SinghaniaSpeaking at the ET NOW Markets Summit 2026, Singhania said that although valuations in the sector have become more reasonable after the sha...
12 years of govt: Share of services sector in total exports jumps to 49% in FY26India's services exports saw a substantial rise, increasing their share in total exports. This growth was fueled by the IT sector and digit...
NBFCs and private banks better positioned than PSU banks: Aman ChowhanAman Chowhan of Abakkus Asset Manager highlights crude oil as the dominant macro risk, potentially impacting corporate earnings by 100-200 ...
FY27 earnings recovery key to next leg of market upmove: Rajeev AgrawalGlobal markets are cautiously optimistic about a potential US-Iran agreement easing geopolitical risks and crude oil volatility. However, I...
Sudip Bandyopadhyay bets on pharma, metals and select cyclicals as geopolitical risks easeEasing West Asia tensions boost global markets, prompting investors to reassess opportunities. Market veteran Sudip Bandyopadhyay favors ph...
'Not a great environment for Indian market': Harsha Upadhyaya on Iran-US tensions, IT outlook, pharma bet, and where to be cautiousGlobal challenges are impacting Indian stocks. West Asian tensions and rising US inflation create headwinds. Tech sector shifts also affect...
India likely past peak outflows, AI gap its advantage, Lighthouse Canton saysDomestic benchmarks Nifty 50 and Sensex are down about 11% and 13% so far in 2026, respectively, after fears of AI-led disruption tanked th...
Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
Q4 FY26 earnings: Metal companies lead growth, backed by robust volumes and favourable pricing trendsET Wealth presents an 8-quarter earnings assessment report of various sectors. The year-on-year net profit growth for 18 sectors is present...